Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium

PHASE2CompletedINTERVENTIONAL

Enrollment

115

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

June 30, 2011

Conditions

Pterygium

Interventions

DRUG

cyclosporine ophthalmic emulsion 0.05%

One drop in the study eye (or eyes) administered four times daily (QID)

DRUG

Vehicle

One drop in the study eye (or eyes) administered four times daily (QID)

Trial Locations (3)

Glendale

Randwick

Singapore